{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:22:19Z","timestamp":1772911339116,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clinre.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:39:57Z","timestamp":1605245997000},"page":"101559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy"],"prefix":"10.1016","volume":"45","author":[{"given":"Cl\u00e9ment","family":"Barjon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-7650","authenticated-orcid":false,"given":"G\u00e9raldine","family":"Dahlqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaldoun","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faouzi","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Aoudjehane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8104","key":"10.1016\/j.clinre.2020.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"312","author":"Calne","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinre.2020.10.004_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cyto.a.22019","article-title":"Immunological advantages of everolimus versus cyclosporin A in liver-transplanted recipients, as revealed by polychromatic flow cytometry","volume":"81","author":"Roat","year":"2012","journal-title":"Cytometry A"},{"issue":"6","key":"10.1016\/j.clinre.2020.10.004_bib0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cld.817","article-title":"Does the liver provide immunosuppressive advantage?","volume":"13","author":"Levitsky","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"5","key":"10.1016\/j.clinre.2020.10.004_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2017.10.007","article-title":"Tolerance in clinical liver transplantation","volume":"79","author":"Levitsky","year":"2018","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1499-3872(13)60002-8","article-title":"Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects","volume":"12","author":"Liu","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.25579","article-title":"Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients","volume":"57","author":"Levitsky","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.clinre.2020.10.004_bib0040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/TP.0b013e3181d3c9d4","article-title":"Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation","volume":"89","author":"Lim","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trim.2012.05.001","article-title":"Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo","volume":"27","author":"Wu","year":"2012","journal-title":"Transpl Immunol"},{"issue":"7","key":"10.1016\/j.clinre.2020.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.14212","article-title":"Efficacy and safety of everolimus and mycophenolic acid with early tacrolimus withdrawal after liver transplantation: a multicenter randomized trial","volume":"17","author":"Saliba","year":"2017","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.clinre.2020.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/lt.25664","article-title":"Early switch from tacrolimus to everolimus after liver transplantation: outcomes at 2 years","volume":"25","author":"Saliba","year":"2019","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.clinre.2020.10.004_bib0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2011.04.020","article-title":"Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C","volume":"43","author":"Ferri","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2020.10.004_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2020.10.004_bib0070","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.clinre.2020.10.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216300","article-title":"Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-low dose tacrolimus with everolimus versus standard dose tacrolimus with mycophenolate mofetil","volume":"14","author":"Traitanon","year":"2019","journal-title":"PLoS one"},{"issue":"n\/a","key":"10.1016\/j.clinre.2020.10.004_bib0080","article-title":"Immunosuppression withdrawal in liver transplant recipients on sirolimus","volume":"n\/a","author":"Levitsky","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2020.10.004_bib0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/tri.13621","article-title":"HCC recurrence in HCV-infected patients after liver transplantation: SiLVER study reveals benefits of sirolimus in combination with CNIs \u2014 a post-hoc analysis","author":"Werner","year":"2020","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial","volume":"100","author":"Geissler","year":"2016","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.clinre.2020.10.004_bib0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clinre.2017.10.001","article-title":"Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity","volume":"42","author":"Ghazal","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2020.10.004_bib0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2249.2006.03048.x","article-title":"Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels","volume":"144","author":"Bolacchi","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.clinre.2020.10.004_bib0105","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/j.1600-6143.2009.02743.x","article-title":"Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation","volume":"9","author":"Carpentier","year":"2009","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.clinre.2020.10.004_bib0110","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.transproceed.2007.07.076","article-title":"Reduced numbers of blood natural regulatory t cells in stable liver transplant recipients with high levels of calcineurin inhibitors","volume":"39","author":"San Segundo","year":"2007","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.clinre.2020.10.004_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.20612","article-title":"Low circulating regulatory T-cell levels after acute rejection in liver transplantation","volume":"12","author":"Demirkiran","year":"2006","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.clinre.2020.10.004_bib0120","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.transproceed.2011.03.084","article-title":"Decreased circulating CD4+CD25highFoxp3+ t cells during acute rejection in liver transplant patients","volume":"43","author":"He","year":"2011","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.clinre.2020.10.004_bib0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1399-3046.2008.00917.x","article-title":"Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients","volume":"13","author":"Stenard","year":"2009","journal-title":"Pediatr Transplant"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120303004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120303004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:23Z","timestamp":1761895823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740120303004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2210740120303004"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2020.10.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101559"}}